E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/26/2007 in the Prospect News PIPE Daily.

Medical Discoveries issues warrants for 17 million shares

By Laura Lutz

Des Moines, Oct. 26 - Medical Discoveries, Inc. issued warrants for 17 million shares of its common stock to holders of its series A preferred convertible stock, according to an 8-K filing with the Securities and Exchange Commission.

Mercator Momentum Fund, LP; Monarch Pointe Fund, Ltd.; and Mercator Momentum Fund III, LP bought the preferreds in private placements in 2004 and 2005.

Mercator Momentum Fund received warrants for 5,122,100 shares, Monarch Pointe received warrants for 6,050,300 shares and Momentum Fund III received warrants for 5,827,600 shares.

The warrants are exercisable at $0.01 until Oct. 17, 2017.

The strike price will be adjusted if the company issues more stock or equity-based securities or if it pays cash - other than dividends - to its stockholders.

Based in Los Angeles, Medical Discoveries is focused on commercializing oil from the Jatropha plant. The company's stock closed unchanged at $0.075 on Oct. 26 (Pink Sheets: MLSC).


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.